Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DiaceuticsDIUXF 80 EV-to-OCF is 90.12 as of Jul. 16, 2026, which is 23% above its 10-year median of 73.49. GuruFocus rates DIUXF with a GF Score™ of 80/100 and a GF Value™ of $2.05 (Fairly Valued). The stock has 1 warning sign investors should review. Among 686 Healthcare Providers & Services companies, Diaceutics ranks worse than 96.06% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Diaceutics's Enterprise Value is $143.21 Mil.
Diaceutics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $1.59 Mil. Therefore, Diaceutics's EV-to-OCF for today is 90.12.
The historical rank and industry rank for Diaceutics's EV-to-OCF or its related term are showing as below:
DIUXF'
s EV-to-OCF Range Over the Past 10 Years
Min: -167.45 Med: 73.49 Max: 355.94
Current: 97.04
During the past 10 years, the highest EV-to-OCF of Diaceutics was 355.94. The lowest was -167.45. And the median was 73.49.
DIUXF's EV-to-OCF is ranked worse than 96.06% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 8.715
vs DIUXF: 97.04
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Diaceutics's share price for today is $2.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diaceutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Diaceutics EV-to-OCF Related Terms
Diaceutics EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Diaceutics's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Diaceutics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diaceutics EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diaceutics's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Diaceutics's EV-to-OCF falls into.
Diaceutics's current Enterprise Value is $143.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Diaceutics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $1.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diaceutics (DIUXF) has a EV-to-OCF of 90.12 as of Jul. 16, 2026. This is 23% above median its historical median of 73.49. According to the industry distribution chart, Diaceutics ranks #659 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 96.1%.
Is Diaceutics' EV-to-OCF too high?
Diaceutics' current EV-to-OCF of 90.12 is 23% above median its 10-year median of 73.49. The Healthcare Providers & Services industry median EV-to-OCF is 8.72. Diaceutics' value of 90.12 is 934.1% above this industry median. Based on the distribution chart, Diaceutics ranks #659 out of 686 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Diaceutics has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diaceutics ranks #659 out of 686 companies for EV-to-OCF. This places Diaceutics in the lower half of its industry. The industry median EV-to-OCF is 8.72. Diaceutics' value of 90.12 is 934.1% above this benchmark. While the company's 10-year median is 73.49 vs. the industry median of 8.72, Diaceutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.72, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diaceutics's current EV-to-OCF of 90.12 is 934.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diaceutics's current EV-to-OCF is 90.12, which is 23% above median its own 10-year median of 73.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Based on GuruFocus' analysis, Diaceutics (DIUXF) is currently considered Fairly Valued. The stock's GF Value™ is $2.05, compared to a current price of $2.00 — trading 2.4% below its estimated fair value. The current EV-to-OCF is 90.12, which is 23% above median its 10-year median of 73.49 and 934.1% above the Healthcare Providers & Services industry median of 8.72. Diaceutics' overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Diaceutics (DIUXF), the current EV-to-OCF is 90.12 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diaceutics (DIUXF) Overvalued in 2026?
Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued.
The current stock price of $2.00 is trading 2.4% below its estimated GF Value™ of $2.05.
GuruFocus considers Diaceutics to be Fairly Valued.
Key valuation signals for DIUXF:
EV-to-OCF: 90.12 (23% above median its 10-year median of 73.49)
GF Value™: $2.05 vs. price of $2.00 (2.4% below fair value)
Industry Position: 934.1% above the Healthcare Providers & Services median (#659 of 686)
No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
80GF Score
Get the complete analysis for DIUXF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DIUXF has been successfully added to your 
